Tratamiento antiagregante de muy corta duración tras la ICP y nuevos SLF: metanálisis de 5 estudios aleatorizados
Authors:
- Monica VerdoiaMVMonica Verdoia
- Elvin KhediEKElvin Khedi
- Harry SuryapranataHSHarry Suryapranata
- Giuseppe De LucaGLGiuseppe De Luca
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 74 (2) , 140-148
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialThe Lancet, 2013
- A New Strategy for Discontinuation of Dual Antiplatelet TherapyJACC, 2012
- Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial InfarctionJAMA, 2012
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- Drug-Eluting vs Bare-Metal Stents in Primary AngioplastyArchives of internal medicine (1960), 2012
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting StentsCirculation, 2012
- Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trialsEuropean Heart Journal, 2009
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical ImplicationsJACC, 2009
- Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)American Heart Journal, 2005